Tang et al. reported that the high expression of MYEOV promoted glycolysis in the tumor cells in pancreatic ductal adenocarcinoma, which was validated in cellular assays (Tang et al. 2020). This evidence concerns the gene MYEOV and pancreatic ductal adenocarcinoma.